Jagsonpal Pharmaceuticals posts Q3 FY26 profit at Rs. 10.95 Cr

Jagsonpal Pharmaceuticals posts Q3 FY26 profit at Rs. 10.95 Cr

By: IPP Bureau

Last updated : January 24, 2026 12:39 pm



Jagsonpal Pharmaceuticals has reported total income of Rs. 75.92 crore during the period ended December 31, 2025


Jagsonpal Pharmaceuticals Ltd. has reported standalone financial results for the period ended December 31, 2025.

Jagsonpal Pharmaceuticals has posted net profit of Rs. 10.95 crore for the period ended December 31, 2025 as against net profit of Rs. 12.57 crore for the period ended September 30, 2025. The company has posted net profit of Rs. 31.99 crore for the period ended December 31, 2024.

Jagsonpal Pharmaceuticals has reported total income of Rs. 75.92 crore during the period ended December 31, 2025 as compared to Rs. 77.49 crore during the period ended September 30, 2025. The company reported total income of Rs. 76.34 crore during the period ended December 31, 2024.

For the 9 months period ended December 31, 2025, Jagsonpal Pharmaceuticals has reported total income of Rs. 231.84 crore as compared to Rs. 215.57 crore during the 9 months period ended December 31, 2024.

The company has posted net profit of Rs. 34.32 crore for the 9 months period ended December 31, 2025 as against net profit of Rs. 48.77 crore for the 9 months period ended December 31, 2024.

Jagsonpal Pharmaceuticals Ltd.

First Published : January 24, 2026 12:00 am